Although direct molecular interactions between RAC2 and PTTG1 have not been conclusively established, existing evidence indicates that these proteins co-regulate critical cancer-related pathways, including epithelial–mesenchymal transition (EMT), immune evasion, and tumor progression. The gene discussed is PTTG1; the disease is cancer.